Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Protea Appoints President | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Protea Appoints President

Halverson brings more than 20 years of management experience in the pharmaceutical services industry

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

David Halverson has been appointed president of Protea Biosciences. He has more than 20 years of management experience in the pharmaceutical services industry, including serving as a director of sales for PPD Discovery and the Quintiles Preclinical Groups. 
 
Mr. Halverson previously served as Protea’s vice president and chief business officer. Prior to joining the company, he was served in various capacities at Huntingdon Life Sciences, including head of European and U.S. sales.  
 
“We are pleased to announce the selection of David Halverson as president of Protea Biosciences,” said Steve Turner, Protea’s chairman and chief executive officer. “David has led the successful development of our proprietary molecular information services business. He is building a strong and growing customer base, which now includes major pharmaceutical and biotechnology companies; he is ideally suited to manage our business operations, as we position Protea to meet and lead the global demand for better molecular information, for improved pharmaceutical development.”  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters